Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...

Ono will assist with Vertex's clinical trials for povetacicept and handle marketing approvals in Japan and South Korea, focusing on IgAN and pMN with possible additional uses.

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

Ono will assist with Vertex's clinical trials for povetacicept and handle marketing approvals in Japan and South Korea, focusing on IgAN and pMN with possible additional uses.

-Approximately 4,000 people living with CF in the European Union are newly eligible for a medicine that treats the underlying cause of their disease for the first time- Vertex Pharmaceuticals (Nasdaq: ...

An analyst recently pegged the Denver Broncos as a "sneaky team" to acquire a Detroit Lions veteran defender who was cut earlier this offseason after the team couldn't afford his $11 million or so ...

The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as sy ...